Aug 2026· Archives of Endocrinology and Metabolism· Vol 70, pp. 1-7· 0 citations· 31 references
Medicine
TL;DR
The coexistence of thyroiditis in patients with PTC was associated with more favorable clinicopathological features, and the findings suggest an association with less aggressive initial presentation rather than a definitive prognostic impact.
Abstract
Objective This study aimed to evaluate the impact of coexisting autoimmune thyroiditis (HT) on the clinicopathological characteristics and prognosis of patients with papillary thyroid carcinoma (PTC). Subjects and methods This prospective study included patients diagnosed with papillary thyroid carcinoma who underwent thyroid surgery. Patients were divided into two groups according to the presence or absence of histologically confirmed thyroiditis. Demographic data, tumor characteristics, pathological features, and postoperative outcomes were analyzed. Statistical comparisons were performed to assess differences between the two groups. Results Thyroiditis was observed in a significant proportion of patients with PTC. Patients with associated thyroiditis showed smaller tumors and more favorable clinicopathological characteristics compared to those without thyroiditis. However, no significant differences were observed in major oncological outcomes. Recurrence rates were lower in the thyroiditis group. The presence of thyroiditis was associated with more favorable prognostic features. Conclusion The coexistence of thyroiditis in patients with PTC was associated with more favorable clinicopathological features. However, no significant differences were observed in major oncological outcomes, and the short follow-up period limits the assessment of long-term prognosis. These findings suggest an association with less aggressive initial presentation rather than a definitive prognostic impact.
Background. Papillary thyroid carcinoma (PTC) coexisting with autoimmune thyroiditis (AIT) remains a controversial issue in thyroidology. The need to identify new cytomorphological criteria for malignancy in the context of chronic inflammation is critical to avoid false-positive diagnoses. The purpose was to investiga...
H. Zelinska, M. O. Mishchenko, O. Kefeli-Yanovska· International Journal of End...· 0 citations
Background and Purpose: To evaluate the impact of chronic viral hepatitis (HBV, HCV) and thyroid autoimmunity on the clinicopathological aggressiveness of papillary thyroid carcinoma (PTC).Methods: This retrospective study included 521 patients with histologically confirmed PTC. Clinicopathological parameters were comp...
Gökçen Güngör Semiz, Sabay Akbaş, Selda Arslan et al.· Journal of Basic and Clinica...· 0 citations
Clinical warning symptoms combined with ultrasound findings improved preoperative risk stratification and may support earlier diagnosis and appropriate surgical management in resource-limited settings.
Concomitant HT is associated with a reduced metastatic burden rather than an increased prevalence of CLNM in patients with papillary thyroid carcinoma (PTC), and the necessity of prophylactic central lymph node dissection warrants individualized assessment combining clinical data and intraoperative observations to avoi...
Higher BMI is independently associated with thyroid malignancy in GD and may serve as a clinically relevant adjunctive risk marker and support more individualized surgical decision-making in patients with GD.
O. Çalişkan, M. T. Unlu, I. Çetinoğlu et al.· The Laryngoscope· 0 citations
Objective: To investigate the prevalence of thyroid cancer (TC) in the Republic of Tajikistan, analyze its clinical and morphological characteristics, and assess the cytokine status of affected patients. Methods: This retrospective study analyzed data from patients treated at the Republican Oncology Scientific Center o...
D. Sanginov, F. I. Salimov, SH.Z. Khabibullaev et al.· Avicenna Bulletin· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.